These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9365500)
1. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Monks A; Scudiero DA; Johnson GS; Paull KD; Sausville EA Anticancer Drug Des; 1997 Oct; 12(7):533-41. PubMed ID: 9365500 [No Abstract] [Full Text] [Related]
2. [Antitumor drug screening at the National Cancer Institute, U.S.A]. Tsuruo T Gan To Kagaku Ryoho; 1987 Oct; 14(10):2809-15. PubMed ID: 3310904 [TBL] [Abstract][Full Text] [Related]
3. Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations. Fojo T; Farrell N; Ortuzar W; Tanimura H; Weinstein J; Myers TG Crit Rev Oncol Hematol; 2005 Jan; 53(1):25-34. PubMed ID: 15607933 [TBL] [Abstract][Full Text] [Related]
4. Update on NCI in vitro drug screen utilities. Holbeck SL Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034 [TBL] [Abstract][Full Text] [Related]
5. Realistic rodents? Debate grows over new mouse models of cancer. Garber K J Natl Cancer Inst; 2006 Sep; 98(17):1176-8. PubMed ID: 16954466 [No Abstract] [Full Text] [Related]
6. Flasks, fibres and flanks--pre-clinical tumour models for predicting clinical antitumour activity. Newell DR Br J Cancer; 2001 May; 84(10):1289-90. PubMed ID: 11355935 [No Abstract] [Full Text] [Related]
7. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action. Huang R; Wallqvist A; Thanki N; Covell DG Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895 [TBL] [Abstract][Full Text] [Related]
9. Anticancer drug development at the US National Cancer Institute. Takimoto CH Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S29-33. PubMed ID: 12819935 [TBL] [Abstract][Full Text] [Related]
12. The role of the National Cancer Institute in drug development. Doroshow J Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997 [No Abstract] [Full Text] [Related]
13. Developing new agents for the treatment of childhood cancer. Kurmasheva R; Morton C; Houghton PJ Curr Opin Investig Drugs; 2005 Dec; 6(12):1215-27. PubMed ID: 16372407 [TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351 [TBL] [Abstract][Full Text] [Related]
15. Assessment of in vitro and in vivo activities in the National Cancer Institute's anticancer screen with respect to chemical structure, target specificity, and mechanism of action. Huang R; Wallqvist A; Covell DG J Med Chem; 2006 Mar; 49(6):1964-79. PubMed ID: 16539384 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen. Gunnarsdottir S; Elfarra AA Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen. Huang R; Wallqvist A; Covell DG Genomics; 2006 Mar; 87(3):315-28. PubMed ID: 16386875 [TBL] [Abstract][Full Text] [Related]
18. Intellectual property. DuPont ups ante on use of Harvard's OncoMouse. Marshall E Science; 2002 May; 296(5571):1212. PubMed ID: 12016275 [No Abstract] [Full Text] [Related]
19. The hollow fibre model in cancer drug screening: the NCI experience. Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037 [TBL] [Abstract][Full Text] [Related]
20. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen. Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]